Australia's Genetic Signatures climbs on TGA registering COVID-19 diagnostic kit

Genetic Signatures

10/01/2022 01:08

** Shares of Genetic Signatures Ltd  GSS.AX  rise as much as
6.9% to A$1.780, their biggest intraday pct gain since Dec 30
    ** The molecular diagnostics firm says the Therapeutic Goods
Administration (TGA) registered a saliva-based protocol using
co's 3base EasyScreen SARS-CoV-2 Detection Kit  urn:newsml:reuters.com:*:nASX6KB09h
    ** These saliva samples will be used for collecting and
testing patient samples for SARS-CoV-2, the virus responsible
for COVID-19
    ** About 133,169 shares change hands, vs the 30-day avg
volume of 1,12,833
    ** Stock has fallen 7% this year, as of last close

 (Reporting by Yamini C S)
 ((Yamini.CS@thomsonreuters.com;))